Product catalog
contact us
    KCI BioTech (Suzhou) Inc.
    Tel:0512-69998806
    Enterprise email:bd@kcibiotech.com
    BD contact information:
    North China:Mr. Xiong 15339988450
    East and South China:Ms. Gu 15378638068
    East China:Mr. Hou 13185096531
    Central and Western regions: Ms. Xiang 15828112963
    Address: Building A2, Xinyang Industrial Park, No. 8 Yanghua Road, Suzhou Industrial Park

Key Model for Drug Development of Rheumatoid Arthritis

  Rheumatoid arthritis (RA) is an autoimmune disease that is pathologically based on synovitis and may eventually lead to joint deformities. Although there is no complete cure for the disease for the time being, early disease control and maintenance therapy can effectively slow down disease progression and improve patients' quality of life.
  We have established a stable model of rheumatoid arthritis, which is suitable for the study of preclinical rheumatoid arthritis drugs and the evaluation of new drugs.
  If you have a project need and experience more of our professional services, please contact us.

Our services

Disease name

Model name

Animal species

Rheumatoid arthritis

Collagen antibody induced arthritis (CAIA) model

mouse

Type II collagen induced rheumatoid arthritis model

mouse, rat

Adjuvant induced rheumatoid arthritis model

rat

Yeast polysaccharide A (ZIA) induced rheumatoid arthritis model

mouse

Non human primate spontaneous rheumatoid arthritis model

Non-human primates


Case sharing

NHP spontaneous rheumatoid arthritis model



Previous:Osteoporosis
Next:Joint fibrosis